Request Deal Involvement
Curaleaf completed the acquisition of a 55% stake in Four 20 Pharma.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Paul Hastings
financial advisors
Parklane Capital
legal advisors
Gleiss Lutz
legal advisors
Ebner Stolz
or
Principals
target
FOUR 20 PHARMA
bidder
CURALEAF HOLDINGS INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite